Antipsychotic medication use in nursing homes: A proposed measure of quality

International Journal of Geriatric Psychiatry

Volumn 29, Issue 10, 2014, Pages 1049-1061

  Lucas, Judith A ^a   Chakravarty, Sujoy ^b   Bowblis, John R ^c   Gerhard, Tobias ^d   Kalay, Ece ^e   Paek, Eun Kwang ^e   Crystal, Stephen ^e  

^a SETON HALL UNIVERSITY   (United States)

^b Rutgers University   (United States)

^c MIAMI UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AGED; ARTICLE; CORRELATIONAL STUDY; DRUG USE; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; NURSING HOME PATIENT; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; TREATMENT INDICATION; CROSS-SECTIONAL STUDY; FEASIBILITY STUDY; HOME FOR THE AGED; PSYCHOTIC DISORDERS; STANDARDS; STATISTICAL MODEL; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION REVIEW; FEASIBILITY STUDIES; FEMALE; GUIDELINE ADHERENCE; HOMES FOR THE AGED; HUMANS; LOGISTIC MODELS; MALE; NURSING HOMES; PRACTICE GUIDELINES AS TOPIC; PSYCHOTIC DISORDERS; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 84908693037     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4098     Document Type: Article

References (50)

1. Alexopoulos GS, Streim E, Carpenter D. 2004. Expert consensus guidelines for using antipsychotic agents in older patients. J Clin Psychiatry 65(Suppl. 2): 100-102.
2. American Geriatrics Society. 2011. Guide to the management of psychotic disorders and neuropsychiatric symptoms of dementia in older adults. Available at: Www. americangeriatrics.org . Accessed July 28, 2012.
3. American Geriatrics Society and American Association for Geriatric Psychiatry. 2003. Consensus statement on improving the quality of mental health care in U. S. nursing homes: Management of depression and behavioral symptoms associated with dementia. J Am Geriatr Soc 51(9): 1287-1298.
4. American Medical Directors Association (AMDA). 2009. Dementia Clinical Practice Guideline. AMDA: Columbia MD.
5. Bowblis JR, Lucas JA. 2012. The impact of state regulations on nursing home care practices. J Regul Econ. DOI: 10.1007/s11149-012-9183-6
6. Bowblis JR, Crystal S, Intrator O, Lucas JA. 2010. Response to regulatory stringency: The case of antipsychotic medication use in nursing homes. Health Econ 21: 977-993.
7. Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. 2005. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 165: 1280-1285.
8. Centers for Medicare and Medicaid Services (CMS). 2004. Interpretive guidelines for long-Term facilities, appendix PP-guidance to surveyors for long-Term care facilities. In State Operations Manual. CMS: Baltimore MD.
9. Centers for Medicare and Medicaid Services (CMS). 2006. Interpretive guidelines for long-Term facilities, appendix PP-guidance to surveyors for long-Term care facilities. In State Operations Manual. CMS: Baltimore MD.
10. CMS Press Release, May 30, 2012. CMS announces partnership to improve dementia care. Available at: Www.CMS.gov. Accessed May 30, 2012.
11. Comondore VR, Devereaux P J, Zhou Q, et al. 2009. Quality of care in for-profit and not-for-profit nursing homes: Systematic review and meta-Analysis. BMJ: Br Med J 339(7716): 381-384.
12. Crystal S, Olfson M, Huang C, et al. 2009. Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Aff 28: 770-781.
13. Feng Z, Katz PR, Intrator O, et al. 2005. Physician and nurse staffing in nursing homes: The role and limitations of the online survey certification and reporting (OSCAR) system. J Am Med Dir Assoc 6(1): 27-33.
14. Fries BE, Schneider DP, Foley WJ, et al. 1994. Refining a case-mix measure for nursing homes: Resource Utilization Groups (RUG-III). Med Care 32(7): 668-685.
15. Gerhard T, Lucas JA, Olfson M, et al. 2008. Effect of regulatory warnings on antipsychotic prescribing for nursing home residents with dementia. Pharmacoepidemiol Drug Saf 17(Suppl 1): S120-121.
16. Glick ID, Murray SR, Vasudevan P, et al. 2001. Treatment with atypical antipsychotics: New indications and new populations. J Psychiatr Res 35: 187-191.
17. Grabowski DC, Angelelli J, Mor V. 2004. Medicaid payment and risk-Adjusted nursing home quality. Health Aff 23(5): 243-252.
18. Grabowski D, Bowblis JR, Lucas JA, Crystal S. 2011. Labor prices and the treatment of nursing home residents with dementia. Int J Econ Bus 18(2): 273-292.
19. Haglund K. 2012. Pressure on antipsychotic prescribing predicted. Caring Ages: Off Publ AMDA 13(5): 1-2.
20. Harrington C, Zimmerman D, Karon SL, Robinson J, Beutel P. 2000. Nursing home staffing and its relationship to deficiencies. J Gerontol 55B(5): S278-S287.
21. Harrington C, Carrillo H, LaCava C. 2006. Nursing Facilities, Staffing, Residents, and Facility Deficiencies, 1999 Through 2005. University of California, Dept. of Social and Behavioral Sciences: San Francisco, CA.
22. Hawes C, Morris J, Phillips CD, et al. 1995. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist 35: 172-178.
23. Hughes CM, Lapane KL. 2005. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: How successful have they been? Drugs Aging 22(4): 339-351.
24. Hughes C, Lapane K, Mor V. 1999. Impact of legislation on nursing home care in the United States: Lessons for the United Kingdom. Br Med J 319(7216): 1060-1062.
25. Huybrechts K F, Schneeweiss S, Gerhard T, et al. 2012. Comparative safety of antipsychotic medications in nursing home residents. J Am Geriatr Soc. DOI: 10.1111/j.1532-5415.2011.03853.x; 0002-8614/12.
26. Institute of Medicine. 1986. Improving the Quality of Care in Nursing Homes. National Academy Press: Washington, DC.
27. Intrator O, Feng Z, Mor V, et al. 2005. The employment of nurse practitioners and physician assistants in U.S. nursing homes. Gerontologist 45(4): 486-495.
28. Jeste DV. 2008. ACNP white paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 33: 957-97.
29. Kales HC, Zivin K, Hyungjin MK, Valenstein M, Chiang C. 2011. Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry 68(2): 190-197.
30. Kamble P, Chen H, Sherer J, et al. 2008. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 6(4): 187-197.
31. Kuehn BM. 2005. FDA warns antipsychotic drugs may be risky for elderly. JAMA 293(20): 2462.
32. Lau DT, Kasper JD, Potter DEB, et al. 2004. Potentially inappropriate medication prescriptions among elderly nursing home residents: Their scope and associated resident and facility characteristics. Health Serv Res 39(5): 1257-1276.
33. Liperoti R, Mor V, Lapane KL, et al. 2003. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 64(9): 1106-1112.
34. Mor V. 2004. A comprehensive clinical assessment tool to inform policy and practice: Applications of the Minimum Data Set. Med Care 42(4 Suppl III): 50-59.
35. Mor V, Berg K, Angelelli J, et al. 2003. The quality of quality measurement in U.S. nursing homes. Gerontologist 43(spec.issue II): 37-46.
36. Mukamel D, Weimer D, Spector W, et al. 2008. Publication of quality report cards and trends in reported quality measures in nursing homes. Health Res Educ Trust 43(4): 1244-1262.
37. National Consumer Voice for Quality Long-Term Care. 2011. Consumer group asks HHS for policies to end chemical restraint on nursing home residents. Available at: Http://theconsumervoice.org/sites/default/files/nccnhr/consumer-voice-statement-foraging-committee-hearing-on-Antipsychotics-11-30-11.pdf. Accessed 8/8/12.
38. Office of Inspector General (OIG). 2011. Medicare atypical antipsychotic drug claims for elderly nursing home residents. DHHS, OIG. OEI-07-08-00150. Available at: Http://oig.hhs.gov/
39. Ray WA, Federspiel CF, Schaffner W. 1980. A study of antipsychotic drug use in nursing homes: Epidemiologic evidence suggesting misuse. Am J Public Health 70: 485-491.
40. Rochon P, Normand S, Gomes T, et al. 2008. Antipsychotic therapy and shortterm serious events in older adults with dementia. Arch Intern Med 168: 1090-1096.
41. Schneeweiss S, Setoguchi S, Brookhart A, et al. 2007. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly residents. CMAJ 176: 627-632.
42. Schneider LS, Dagerman K, Insel P. 2006a. Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-Analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 14(3): 191-210.
43. Schneider L, Tariot P, Dagerman K. 2006b. Effectiveness of atypical antipsychotic drugs in residents with Alzheimer's disease. N Engl J Med 355: 1525-1538.
44. Shekelle P, Maglione M, Bagley S, et al. 2007. Efficacy and comparative effectiveness of off-label use of atypical antipsychotics. Comparative Effectiveness Review No. 6.
45. Agency for Healthcare Research and Quality: Rockville, MD. Available at: Http://www.effectivehealthcare. ahrq.gov/ehc/products/5/63/Atypical-Antipsychotics-Final-Report.pdf.
46. Simoni-Wastila L, Ryder PT, Qian J, et al. 2009. Association of antipsychotic use with hospital events and mortality among Medicare beneficiaries residing in long-Term care facilities. Am J Geriatr Psychiatr 17(5): 417-427.
47. Snowden M, McCormick W, Russo J, et al. 1999. Validity and responsiveness of the Minimum Data Set. J Am Geriatr Soc 47(8): 1000-1004.
48. Stevenson DG, Decker SL, Dwyer LL, et al. 2010. Antipsychotic and benzodiazepine use among nursing home residents: Findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry 18(12): 1078-1092.
49. Trifiro G, Spina E, Gambassi G. 2009. Use of antipsychotics in elderly patients with dementia: Do atypical and conventional agents have a similar safety profile? Pharmacol Res 59(1): 1-12.
50. Werner RM, Asch DA. 2005. The unintended consequences of publicly reporting quality information. JAMA 293(10): 1239-1244.